AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,560
-390 (-2.17%)
At close: Jul 11, 2025, 3:30 PM KST

AprilBio Revenue

AprilBio had revenue of 2.17B KRW in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 29.69B. In the year 2024, AprilBio had annual revenue of 27.51B.

Revenue (ttm)
29.69B
Revenue Growth
n/a
P/S Ratio
13.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
395.58B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 27.51B - -
Dec 31, 2023 - - -
Dec 31, 2022 200.00M -23.20B -99.15%
Dec 31, 2021 23.40B - -
Dec 31, 2020 - - -
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
Samsung Biologics 4,898.69B
LG Energy Solution 25.76T
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Doosan Enerbility 15.88T
Celltrion 3,662.23B
Revenue Rankings